價(jià)格 | ¥483 | ¥1160 | ¥1820 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 A-674563 | 英文名稱:A-674563 |
CAS:552325-73-2 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.21% | 產(chǎn)品類別: 抑制劑 |
貨號(hào): T6139 |
Name | A-674563 |
Description | A-674563 is an Akt1 inhibitor with Ki of 11 nM, modest potent to PKA and >30-fold selective for Akt1 over PKC. |
Cell Research | The cells on 96-well plates are gently washed with 200 μL of PBS. Alamar Blue reagent is diluted 1:10 in normal growth media. The diluted Alamar Blue reagent (100 M) is added to each well on the 96-well plates and incubated until the reaction is complete as per manufacturer's instructions. Analysis is done using an fmax Fluorescence Microplate Reader, set at the excitation wavelength of 544 nm and emission wavelength of 595 nm. Data are analyzed using SOFTmax PRO software provided by the manufacturer. (Only for Reference) |
Kinase Assay | Akt Kinase Assay: The kinase assay uses His-Akt1 and a biotinylated mouse Bad peptide as substrate. The kinase assay is carried out at room temperature for 30 minutes in 50 μL of reaction buffer [20 mM HEPES, pH 7.5, 10 mM MgCl2, 0.1% (w/v) Triton X-100, 5 μM ATP (Km = 40 μM), 5 μM peptide (Km = 15 μM), 1 mM DTT, 60 ng of Akt1, and 0.5 μCi of [γ-33P]ATP] in the presence of different concentrations of A-674563. Each reaction is stopped by adding 50 μL of termination buffer (0.1 M EDTA, pH 8.0, and 4 M NaCl). The biotinylated Bad peptides are immobilized on streptavidin-coated FLASH plates. After being washed with PBS-Tween 20 (0.05%), the 33P phosphopeptide captured on the FLASH plates is measured with a TopCount Packard Instruments γ counter. |
In vitro | A-674563是通過(guò)將A-443654中的吲哚基團(tuán)替換為苯基團(tuán)并獲得口服活性而得到的。A-674563能夠以0.4μM的EC50抑制腫瘤細(xì)胞的增殖。[1] A-674563本身不抑制Akt的磷酸化,但能以劑量依賴性方式阻斷Akt下游靶點(diǎn)的磷酸化。A-674563引起的Akt阻斷導(dǎo)致STS細(xì)胞下游靶點(diǎn)磷酸化減少以及腫瘤細(xì)胞生長(zhǎng)抑制。A-674563在STS細(xì)胞中誘導(dǎo)G2細(xì)胞周期阻滯及凋亡。[2] |
In vivo | 在口服葡萄糖耐量測(cè)試中,20 mg/kg A-674563可提高血漿胰島素水平。A-674563單藥治療未顯示出明顯的抑瘤活性;與紫杉醇單藥治療相比,聯(lián)合治療的療效顯著提高。[1]治療的小鼠(20 mg/kg/bid,p.o.)展現(xiàn)出比對(duì)照組更慢的腫瘤生長(zhǎng)速率,并在研究終點(diǎn)時(shí)腫瘤體積減少了50%以上。[2]在小鼠中,A-674563的口服生物利用度為67%,其藥代動(dòng)力學(xué)(PK)特性顯著提高,但其活性比A-443654低70倍。[3] |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O : 66 mg/mL (184.1 mM) DMSO : 67 mg/mL (186.9 mM) Ethanol : 15 mg/mL (41.8 mM) |
Keywords | Protein kinase B | PKB | inhibit | Akt | A-674563 | A 674563 | Inhibitor |
Inhibitors Related | Lidocaine hydrochloride | Astragaloside IV | Lidocaine | Sodium Oxamate | Ribociclib | 4-Chloro-2'-bromoacetophenone | Tauroursodeoxycholate | Artemisinin | Acefylline | 2,3-Butanediol | TBHQ | Abemaciclib |
Related Compound Libraries | Inhibitor Library | Bioactive Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Anti-Aging Compound Library | Pain-Related Compound Library |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP3年
|
河南威梯希化工科技有限公司
|
2024-12-27 | |
¥720.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 | |
¥2677.90 |
VIP13年
|
上海阿拉丁生化科技股份有限公司
|
2024-10-31 | |
詢價(jià) |
南京百鑫德諾生物科技有限公司
|
2024-09-26 | ||
詢價(jià) |
信實(shí)生物醫(yī)藥(上海)有限公司
|
2023-06-03 |